X
<

Why ExxonMobil missed 2Q13 earnings expectations

PART:
1 2 3 4 5 6
Part 4
Why ExxonMobil missed 2Q13 earnings expectations PART 4 OF 6

Why ExxonMobil’s chemical segment was weaker in 2Q13

Chemicals segment was weaker in 2Q13

Quarter-over-quarter, XOM’s chemical segment earnings were down $381 million. The company cited lower margins due to weaker aromatics prices as the reason for the $200 million earnings reduction, partially offset (with $30 million) by an improved sales mix (which generally means more sales volumes of higher-margin products). Aromatics comprise benzene, toluene, and xylenes, which are used in a variety of end products. Prices may have been under pressure either due to weaker demand, more supply, or a combination of both.

Why ExxonMobil&#8217;s chemical segment was weaker in 2Q13

Further, $210 million of the quarter-over-quarter reduction in earnings was due to start-up costs from a new facility in Singapore and the absence of gains from prior quarter asset sales.

Interested in XOM? Receive notifications on the latest research and sign up for a Market Realist account in one simple step:

Suceess! Your Market Realist account has been created and you’ll receive email alerts on the latest research. Check your email for your temporary account password.

Success! has been added to your Ticker Alerts.

Success! has been added to your Ticker Alerts. Click here to manage subscriptions.

X

Please select a profession that best describes you: